Insertion/Deletion Polymorphisms in the Promoter Region of BRM Contribute to Risk of Hepatocellular Carcinoma in Chinese Populations

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Gao, Xueren ^a   Huang, Moli ^a   Liu, Limin ^a   He, Yan ^a   Yu, Qiang ^b   Zhao, Hua ^c   Zhou, Chunxiao ^b   Zhang, Jinkun ^b   Zhu, Zhansheng ^a   Wan, Jiao ^a   Jiang, Xinghong ^a   Gao, Yuzhen ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAHMA HOMOLOG; MESSENGER RNA; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAHMA HOMOLOG GENE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HEPATITIS B; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INDEL MUTATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; ONCOGENE; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; WESTERN BLOTTING;

ADULT; AGED; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CHINA; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84872856095     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055169     Document Type: Article

References (33)

1. Yang JD, Roberts LR, (2010) Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458.
2. McClune AC, Tong MJ, (2010) Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis 14: 461-476.
3. Chen CJ, Chen DS, (2002) Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 36: 1046-1049.
4. Whittaker S, Marais R, Zhu AX, (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29: 4989-5005.
5. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557.
6. Casper M, Grünhage F, Lammert F, (2011) Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark? Hepatology 53: 1390-1392.
7. Wilson BG, Roberts CW, (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481-492.
8. Reisman D, Glaros S, Thompson EA, (2009) The SWI/SNF complex and cancer. Oncogene 28: 1653-1668.
9. Roberts CW, Orkin SH, (2004) The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 4: 133-142.
10. Xia W, Nagase S, Montia AG, Kalachikov SM, Keniry M, et al. (2008) BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer. Cancer Res 68: 1667-1674.
11. Medina PP, Romero OA, Kohno T, Montuenga LM, Pio R, et al. (2008) Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat 29: 617-622.
12. Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK, (2005) The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Appl Immunohistochem Mol Morphol 13: 66-74.
13. Liu G, Gramling S, Munoz D, Weissman BE, Funkhouser WK, et al. (2011) Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. Oncogene 30: 3295-3304.
14. Gao Y, He Y, Ding J, Wu K, Hu B, et al. (2009) An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30: 2064-2069.
15. Chen S, He Y, Ding J, Jiang Y, Jia S, et al. (2010) An insertion/deletion polymorphism in the 3′ untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun 391: 552-556.
16. Yu Q, Zhou CX, Chen NS, Zheng SD, Shen LM, et al. (2012) A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population. World J Gastroenterol 18: 383-387.
17. Allen RC, Graves G, Budowle B, (1989) Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. Biotechniques 7: 736-744.
18. Shi YY, He L, (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15: 97-98.
19. Shen H, Powers N, Saini N, Comstock CE, Sharma A, et al. (2008) The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Res 68: 10154-10162.
20. Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, et al. (2012) Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci U S A 109: E252-259.
21. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE, et al. (2003) Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63: 560-566.
22. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, et al. (2004) Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res 10: 4314-4324.
23. Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, et al. (2007) The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene 26: 7058-7066.
24. Yamamichi N, Yamamichi-Nishina M, Mizutani T, Watanabe H, Minoguchi S, et al. (2005) The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene 24: 5471-5481.
25. Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W Jr, et al. (2002) Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21: 1196-1207.
26. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, et al. (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102: 257-265.
27. Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, et al. (2005) SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65: 3542-3547.
28. Boyault S, Rickman DS, de Reyniès A, Balabaud C, Rebouissou S, et al. (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45: 42-52.
29. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, et al. (2001) Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61: 2129-2137.
30. Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A, et al. (2003) Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 12: 771-776.
31. Sakurai K, Furukawa C, Haraguchi T, Inada K, Shiogama K, et al. (2011) MicroRNAs miR-199a-5p and-3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res 71: 1680-1689.
32. Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, et al. (2012) Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. Carcinogenesis 33: 1617-1628.
33. Kenneth NS, Mudie S, van Uden P, Rocha S, (2009) SWI/SNF regulates the cellular response to hypoxia. J Biol Chem 284: 4123-4131.